U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975813) titled 'Magnesium Sulfate and Trigger Points' on May 09. Brief Summary: The patients will be random... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974513) titled 'Auditory Localization in Schizophrenia' on April 29. Brief Summary: Auditory sound localiza... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975046) titled 'Aerodynamic Measurements in the Pediatric Population' on May 08. Brief Summary: The goal of... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974669) titled 'The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Su... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976268) titled 'A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults ... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975072) titled 'Effect of Magnesium on Neuromonitoring' on March 31. Brief Summary: Intraoperative neurophy... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974968) titled 'Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase ... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975904) titled 'Effect of Modified Constraint-induced Movement Therapy Combined With Virtual Reality on Mobi... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975501) titled 'Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mec... Read More
U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976944) titled 'Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer' on April 30. ... Read More